EZH2 and hepatocellular carcinoma: In both paired and unpaired samples of HCC patients, EZH2, G6PD, LGALS3 and PSMD14 were highly expressed in the cancer and lowly expressed in the paracancer, with statistically significant differences (Fig. 10A-H).